Analysis of General and Oral Quality of Life and Satisfaction with Treatment among Anticoagulated Patients

Sintron® (acenocoumarol) is the most widely prescribed anticoagulant in Spain and is prescribed for the treatment or prevention of thrombotic complications [1-3]. The management of acenocoumarol is complicated by its narrow therapeutic window which necessitates regular blood monitoring to ensure the safety and efficacy of the therapy [1,2]. The international normalized ratio (INR) was developed by the World Health Organization as a means of standardizing prothrombin time results among different laboratories. It is now widely used to monitor oral anticoagulant therapy and dosage planning for patients receiving acenocoumarol.